Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Henry Ford Health Performs Michigan's First Vagus Nerve Implant for Rheumatoid Arthritis

Henry Ford Health Performs Michigan’s First Vagus Nerve Implant for Rheumatoid Arthritis

November 21, 2026 Health Desk Health

Kim Landrith, a 71-year-old resident of Macomb County, received a vagus nerve stimulation device in Detroit on Oct. 26 to manage her rheumatoid arthritis, News-Medical reported.

The procedure marks the first commercial implantation of the SetPoint System in Michigan, providing a new option for patients who have not achieved adequate relief through traditional pharmaceutical interventions.

Key Clinical Takeaways:

  • The SetPoint System uses daily electrical stimulation of the vagus nerve to modulate the body’s inflammatory response.
  • Clinical trials demonstrated that 50% of patients achieved low disease activity or remission after one year of use.
  • The device is designed for adults with moderate to severe rheumatoid arthritis who fail to respond to standard medication protocols.

Rheumatoid arthritis affects approximately 1.5 million Americans, forcing the immune system to attack healthy joint tissue. This autoimmune process leads to chronic pain, swelling, and potential long-term joint destruction. While systemic treatments such as disease-modifying antirheumatic drugs (DMARDs) and biologics remain the standard of care, some patients experience persistent symptoms or adverse drug reactions.

The SetPoint System, developed by the California-based medical technology firm SetPoint Medical, functions by delivering electrical signals to the vagus nerve. This stimulation triggers the body’s natural inflammatory reflex, effectively downregulating the production of cytokines that drive joint inflammation. The device, which is roughly the size of a multivitamin, is implanted in an outpatient procedure lasting 60 to 90 minutes.

Dr. Ellen Air, chair of the Department of Neurosurgery at Henry Ford Health, performed the implantation on Landrith. "Vagus nerve stimulation has been used for years to treat conditions like epilepsy and in stroke recovery, and now we're applying this approach in a new way to help people with rheumatoid arthritis," said Air, who also served as an investigator in the key clinical trial evaluating the system.

Following the surgery, Landrith’s device was activated on Nov. 11. “I’m hoping for more mobility and less pain,” Landrith told News-Medical. “I want to be able to move my hands and fingers, to write my name and to walk without my toes and feet hurting.”

The FDA approved the SetPoint System in July 2025, based on longitudinal data showing sustained efficacy. Clinical studies indicated that patients using the implant experienced measurable improvements within three months. Data showed that more than 75% of participants remained on their existing medication regimen without requiring additional therapies after one year of device use.

Economic projections suggest that this neurostimulation approach may offer long-term financial advantages. An analysis co-authored by Air estimated that the therapy could reduce lifetime healthcare expenditures by more than $350,000 per patient when compared to pharmacological treatment alone.

Henry Ford Health, the integrated nonprofit system founded by Henry Ford in 1915 and headquartered in Detroit, operates 13 hospitals across the Detroit, Flint and Jackson areas and is the second-largest health system in Michigan.

In 2022 the organization rebranded from Henry Ford Health System to Henry Ford Health, and in September 2024 it finalized a joint venture with Ascension that brought the Metro Detroit and Flint operations of Ascension Michigan into a combined organization in which Ascension holds a 20% ownership stake.

Rheumatologist referral leads to neck implantation procedure

Patients currently suffering from refractory rheumatoid arthritis are encouraged to consult with a board-certified rheumatologist to determine if they meet the clinical criteria for this device. Once a referral is made, a neurosurgeon performs the implantation through a small incision in the neck. After the surgical site heals, the device is programmed to deliver one minute of stimulation daily, often during sleep. Patients manage the device using a wearable charger on a weekly basis, and the hardware is engineered to remain functional for up to 10 years.

While the implant offers a novel mechanism for controlling systemic inflammation, it is not a replacement for comprehensive rheumatological management. Patients should continue working with specialists to monitor disease activity and adjust systemic treatments as necessary.

For those facing persistent joint damage despite conventional therapy, discussing emerging neuromodulation options with a rheumatology specialist is a necessary step in evaluating potential candidacy for this procedure.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Keep reading

  • Nature: 11% Darker Skin Tones in 1.1M Dermatology Images
  • Medellín to Host Expl-AI-n 2026 Generative AI Summit Featuring Leaders from Google, Nvidia, and Walmart
  • Paul A. Offit Warned at a New York Symposium That U.S. Health Leaders Are Sowing Dangerous Confusion (archyde.com)

Related

Inflammation, joint pain, Neck, Nerve, Neurosurgery, pain, research, Rheumatoid Arthritis, Therapy

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: [email protected]

Privacy Policy Terms of Service